Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acetylon pharmaceuticals
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
ambys medicines
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cell therapy
ceo
clinical hold
clinical study
combination
commissioner
congress
constellation pharmaceuticals
crispr
crispr-cas9
deals
delisting
democrats
departure
detroit blog main
What
big
2
×
aiming
ambys
bio
biotech
bosley's
bosley’s
bridge
bucks
cas
ceo
control
crime
crispr
deadly
deal
debuted
departure
diseases
editas
exit
formed
future
guiding
katrine
launch
liver
make
medicine
medicines
moves
new
personnel
roundup
startup
surprising
takeda
today
treatments
unusual
Language
Current search:
ipo
×
big
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
